Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Patterson Companies Inc is a medical distribution business based in the US. Patterson Companies shares (PDCO) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Active traders
| Latest market close | $30.09 |
|---|---|
| 52-week range | $26.06 - $35.02 |
| 50-day moving average | $30.68 |
| 200-day moving average | $30.77 |
| Wall St. target price | $35.27 |
| PE ratio | 17.8889 |
| Dividend yield | $1.04 (3.36%) |
| Earnings per share (TTM) | $1.71 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $30.09 from 2022-07-05
| 1 week (2022-06-30) | -0.69% |
|---|---|
| 1 month (2022-06-07) | -4.23% |
| 3 months (2022-04-07) | -10.29% |
| 6 months (2022-01-06) | 3.26% |
| 1 year (2021-07-07) | -0.07% |
|---|---|
| 2 years (2020-07-07) | 32.29% |
| 3 years (2019-07-05) | 33.56% |
| 5 years (2017-07-06) | 44.15 |
Valuing Patterson Companies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Patterson Companies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Patterson Companies's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 18x. In other words, Patterson Companies shares trade at around 18x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Patterson Companies's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0984. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Patterson Companies's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Patterson Companies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $239 million.
The EBITDA is a measure of a Patterson Companies's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $6.5 billion |
|---|---|
| Operating margin TTM | 2.42% |
| Gross profit TTM | $1.3 billion |
| Return on assets TTM | 3.57% |
| Return on equity TTM | 20.1% |
| Profit margin | 3.13% |
| Book value | $10.70 |
| Market capitalisation | $3 billion |
TTM: trailing 12 months
Dividend payout ratio: 45.81% of net profits
Recently Patterson Companies has paid out, on average, around 45.81% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 3.36% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Patterson Companies shareholders could enjoy a 3.36% return on their shares, in the form of dividend payments. In Patterson Companies's case, that would currently equate to about $1.04 per share.
While Patterson Companies's payout ratio might seem fairly standard, it's worth remembering that Patterson Companies may be investing much of the rest of its net profits in future growth.
Patterson Companies's most recent dividend payout was on 5 May 2022. The latest dividend was paid out to all shareholders who bought their shares by 20 July 2022 (the "ex-dividend date").
Patterson Companies's shares were split on a 2:1 basis on 24 October 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Patterson Companies shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Patterson Companies shares which in turn could have impacted Patterson Companies's share price.
Over the last 12 months, Patterson Companies's shares have ranged in value from as little as $26.0631 up to $35.0222. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Patterson Companies's is 1.3299. This would suggest that Patterson Companies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Patterson Companies, Inc. engages in distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.